AIMS: To quantify the prevalence of coronary artery calcification (CAC) in relation to cardiovascular risk factors in marathon runners, and to study its role for myocardial damage and coronary events. METHODS AND RESULTS: In 108 apparently healthy male marathon runners aged >or=50 years, with >or=5 marathon competitions during the previous three years, the running history, Framingham risk score (FRS), CAC, and presence of myocardial late gadolinium enhancement (LGE) were measured. Control groups were matched by age (8:1) and FRS (2:1) from the Heinz Nixdorf Recall Study. The FRS in marathon runners was lower than in age-matched controls (7 vs. 11%, P < 0.0001). However, the CAC distribution was similar in marathon runners and age-matched controls (median CAC: 36 vs. 38, P = 0.36) and higher in marathon runners than in FRS-matched controls (median CAC: 36 vs. 12, P = 0.02). CAC percentile values and number of marathons independently predicted the presence of LGE (prevalence = 12%) (P = 0.02 for both). During follow-up after 21.3 +/- 2.8 months, four runners with CAC >or= 100 experienced coronary events. Event-free survival was inversely related to CAC burden (P = 0.018). CONCLUSION: Conventional cardiovascular risk stratification underestimates the CAC burden in presumably healthy marathon runners. As CAC burden and frequent marathon running seem to correlate with subclinical myocardial damage, an increased awareness of a potentially higher than anticipated coronary risk is warranted.
AIMS: To quantify the prevalence of coronary artery calcification (CAC) in relation to cardiovascular risk factors in marathon runners, and to study its role for myocardial damage and coronary events. METHODS AND RESULTS: In 108 apparently healthy male marathon runners aged >or=50 years, with >or=5 marathon competitions during the previous three years, the running history, Framingham risk score (FRS), CAC, and presence of myocardial late gadolinium enhancement (LGE) were measured. Control groups were matched by age (8:1) and FRS (2:1) from the Heinz Nixdorf Recall Study. The FRS in marathon runners was lower than in age-matched controls (7 vs. 11%, P < 0.0001). However, the CAC distribution was similar in marathon runners and age-matched controls (median CAC: 36 vs. 38, P = 0.36) and higher in marathon runners than in FRS-matched controls (median CAC: 36 vs. 12, P = 0.02). CAC percentile values and number of marathons independently predicted the presence of LGE (prevalence = 12%) (P = 0.02 for both). During follow-up after 21.3 +/- 2.8 months, four runners with CAC >or= 100 experienced coronary events. Event-free survival was inversely related to CAC burden (P = 0.018). CONCLUSION: Conventional cardiovascular risk stratification underestimates the CAC burden in presumably healthy marathon runners. As CAC burden and frequent marathon running seem to correlate with subclinical myocardial damage, an increased awareness of a potentially higher than anticipated coronary risk is warranted.
Authors: James H O'Keefe; Harshal R Patil; Carl J Lavie; Anthony Magalski; Robert A Vogel; Peter A McCullough Journal: Mayo Clin Proc Date: 2012-06 Impact factor: 7.616
Authors: Fabian Sanchis-Gomar; Laura M Pérez; Michael J Joyner; Herbert Löllgen; Alejandro Lucia Journal: Sports Med Date: 2016-04 Impact factor: 11.136
Authors: Ying Kuen Cheung; Gary Yu; Melanie M Wall; Ralph L Sacco; Mitchell S V Elkind; Joshua Z Willey Journal: Ann Epidemiol Date: 2015-03-23 Impact factor: 3.797
Authors: Thomas Radtke; Arno Schmidt-Trucksäss; Nicolas Brugger; Daniela Schäfer; Hugo Saner; Matthias Wilhelm Journal: Eur J Appl Physiol Date: 2013-10-19 Impact factor: 3.078
Authors: Ying Kuen Cheung; Yeseon P Moon; Erin R Kulick; Ralph L Sacco; Mitchell S V Elkind; Joshua Z Willey Journal: J Gen Intern Med Date: 2016-10-17 Impact factor: 5.128